We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Can Philip Morris' (PM) RRPs Help It Tide Over Hurdles?
Read MoreHide Full Article
With anti-smoking campaigns and strict government regulations striving to curb tobacco consumption, industry giants like Philip Morris International Inc. (PM - Free Report) have been witnessing receding cigarette sales volumes. Amid such adverse industry conditions, Philip Morris has diverted its attention to reduced risk products (RRPs) to propel growth and stay afloat in the industry.
Philip Morris Travels on the Smoke-Free Way
Rising health consciousness and adverse impacts of tobacco consumption have pushed consumers toward RRPs such as e-cigarettes, HeatSticks and iQOS products. To meet consumer’s changing preference, Philip Morris launched the iQOS (in 2014), a smokeless cigarette, in approximately 31 markets globally and catered to more than 3.7 million consumers globally, excluding the United States. In fact, courtesy of growing popularity of such products, Philip Morris generated revenues worth $947 million from RRPs during the third quarter of 2017, up from $212 million reported last year.
Further, the marketing and technology sharing agreement between Philip Morris and Altria Group (MO - Free Report) for selling the former’s iQOS heated tobacco products in the United States, is also expected to aid volume and sales growth for the companies. The agreement is currently submitted for review to the FDA.
Per sources, the FDA is currently carrying out extensive research on whether prolonged usage of iQOS products carries any detrimental impacts on health. If authorities provide a green signal to this product, it may prove to be an important milestone in the path of popularizing less harmful tobacco products in the country.
Stringent Regulations Dent Cigarette Sales
Apart from price hikes and precautionary labels, the FDA has directed tobacco makers to lower nicotine levels in cigarettes to make it less addictive. Such efforts to check tobacco consumption lowered cigarette sales volumes globally. This weighed on the performance of major companies such as British American Tobacco (BTI - Free Report) and Vector Group (VGR - Free Report) .
Incidentally, Philip Morris’ net revenues during third-quarter 2017 were hurt by a 3.6% decline in combustible products. Total shipment volumes in this category also declined 4.1%. As a result, total cigarette and heated tobacco unit shipment volume fell 0.5%.
To make matters worse, the court recently issued an order which guides cigarette companies to put up self-critical advertisements circulated through television, newspapers, social media and store displays. Such headwinds plaguing the tobacco industry are likely to drag Philip Morris’ combustible products category performance in the forthcoming periods as well.
Driven by such headwinds, shares of Philip Morris fell 8.4% in the past six months, compared with the industry’s decline of 2.9%.
Final Thoughts
Nevertheless, this Zacks Rank #3 (Hold) company’s efforts to popularize iQOS products and expand sales in the reduced risk products category are laudable. Even amid adverse industry conditions, Philip Morris is likely to continue benefiting from consumers shift to cigarette alternatives in the forthcoming periods, which will help it lift investors’ optimism.
Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.
Image: Bigstock
Can Philip Morris' (PM) RRPs Help It Tide Over Hurdles?
With anti-smoking campaigns and strict government regulations striving to curb tobacco consumption, industry giants like Philip Morris International Inc. (PM - Free Report) have been witnessing receding cigarette sales volumes. Amid such adverse industry conditions, Philip Morris has diverted its attention to reduced risk products (RRPs) to propel growth and stay afloat in the industry.
Philip Morris Travels on the Smoke-Free Way
Rising health consciousness and adverse impacts of tobacco consumption have pushed consumers toward RRPs such as e-cigarettes, HeatSticks and iQOS products. To meet consumer’s changing preference, Philip Morris launched the iQOS (in 2014), a smokeless cigarette, in approximately 31 markets globally and catered to more than 3.7 million consumers globally, excluding the United States. In fact, courtesy of growing popularity of such products, Philip Morris generated revenues worth $947 million from RRPs during the third quarter of 2017, up from $212 million reported last year.
Further, the marketing and technology sharing agreement between Philip Morris and Altria Group (MO - Free Report) for selling the former’s iQOS heated tobacco products in the United States, is also expected to aid volume and sales growth for the companies. The agreement is currently submitted for review to the FDA.
Per sources, the FDA is currently carrying out extensive research on whether prolonged usage of iQOS products carries any detrimental impacts on health. If authorities provide a green signal to this product, it may prove to be an important milestone in the path of popularizing less harmful tobacco products in the country.
Stringent Regulations Dent Cigarette Sales
Apart from price hikes and precautionary labels, the FDA has directed tobacco makers to lower nicotine levels in cigarettes to make it less addictive. Such efforts to check tobacco consumption lowered cigarette sales volumes globally. This weighed on the performance of major companies such as British American Tobacco (BTI - Free Report) and Vector Group (VGR - Free Report) .
Incidentally, Philip Morris’ net revenues during third-quarter 2017 were hurt by a 3.6% decline in combustible products. Total shipment volumes in this category also declined 4.1%. As a result, total cigarette and heated tobacco unit shipment volume fell 0.5%.
To make matters worse, the court recently issued an order which guides cigarette companies to put up self-critical advertisements circulated through television, newspapers, social media and store displays. Such headwinds plaguing the tobacco industry are likely to drag Philip Morris’ combustible products category performance in the forthcoming periods as well.
Driven by such headwinds, shares of Philip Morris fell 8.4% in the past six months, compared with the industry’s decline of 2.9%.
Final Thoughts
Nevertheless, this Zacks Rank #3 (Hold) company’s efforts to popularize iQOS products and expand sales in the reduced risk products category are laudable. Even amid adverse industry conditions, Philip Morris is likely to continue benefiting from consumers shift to cigarette alternatives in the forthcoming periods, which will help it lift investors’ optimism.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Wall Street’s Next Amazon
Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.
Click for details >>